Minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) has prognostic and predictive significance. One of the approaches to detect MRD by flow cytometry (FC) is the use of dry antibody reagents such as DuraClone® RE CLB (Beckman Coulter—BC). The aim of this study was to evaluate the performance of the DuraClone® RE CLB in detecting MRD in CLL compared to liquid reagents.

中文翻译：

---

八色干抗体试剂在慢性淋巴细胞白血病样本微小残留病检测中的应用

慢性淋巴细胞白血病（CLL）的微小残留病（MRD）具有预后和预测意义。通过流式细胞术 (FC) 检测 MRD 的方法之一是使用干抗体试剂，例如 DuraClone® RE CLB (Beckman Coulter-BC)。本研究的目的是评估 DuraClone® RE CLB 与液体试剂相比在检测 CLL 中的 MRD 方面的性能。